Hypoglycaemic activity of callistemon laceolatus leaf ethanolic extract in streptozotocin induced diabetic rats

Pharmacologyonline

Volumn 1, Issue , 2011, Pages 799-808

  Nazreen, Syed ^a   Kaur, Gurpreet ^a   Alam, Mohammad Mahboob ^a   Haider, Saqlain ^a   Shafi, Syed ^a   Hamid, Hinna ^a   Alam, Mohammad Sarwar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Callistemon lanceolatus DC. hypoglycaemic; Ethanolic extract; Lipid peroxidation; Reduced glutathione

Indexed keywords

CALLISTEMON LANCEOLATUS EXTRACT; CATALASE; CHLOROFORM; FLAVANOID; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLYCOSIDE; PETROLEUM ETHER; PHENOL; PLANT EXTRACT; STEROID; SUPEROXIDE DISMUTASE; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CALLISTEMON LANCEOLATUS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPOGLYCEMIA; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; PHYTOCHEMISTRY; RAT; STREPTOZOCIN DIABETES;

EID: 79955600225     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Physiolog Reviews 1996; 76: 1109-1161.
2. Saxena A, Kishore VN. Role of selected Indian plants in management of type 2 diabetes: A review. J. Alt.Comp Med 2004; 10:369-378.
3. Ojewole JA. Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (Crassulaceae) leaf aqueous extract. J. Ethnopharmacol 2005; 99:13-19.
4. Jia W, Gao W, Tang L, Antidiabetic herbal drugs officially approved in China. Phytotherapy Res 2003; 17: 1127-1134.
5. Oyedeji OO, Lawal AO, Shode OF, Oyedeji OA. Chemical Composition and Antibacterial Activity of the Essential Oils of Callistemon citrinus and Callistemon viminalis from South Africa. Molecules 2009; 14: 1990-1998.
6. Saxena S, Gomber C. Antimicrobial potential of Callistemon rigidus. Pharma. Biology 2006; 3:194-201.
7. Gomber C, Saxena S. Anti-staphylococcal potential of Callistemon rigidus. Central European J. of Med 2007; 2: 79-88.
8. Chistokhodova N, Nguygen C, Calvino T, Kachriskaia I, Cuuingham G, Miles DH. Antithrombin activity of medicinal plants from Florida. J. of Ethnopharmacol 2002; 82: 277-280.
9. Sudhakar M, Rao CHV, Rao AL, Raju DB. Antinociceptive and anti-inflammatory effects of the standardised oil of Indian Callistemon lanceolatus leaves in experimental animals. Acta Pharma. Tur. 2004; 46: 131-139.
10. Hee JK, Byun JC, Bandi AKR, Hyun CG, Lee NH. Compounds with elastase inhibition and free radical scavenging activities from Callistemon lanceolatus. J. of Med Plants Res 2009; 3: 914-920.
11. Kobayashi K, Ishihara T, Khono E, Miyase T, Yoshizaki F. Constituents of stem back of Callistemon rigidus showing inhibitory effects on mouse a-amylase activity. Biol Pharma Bull 2006; 29: 1275-1277.
12. Mahmoud II, Moharram FA, Marzouk MS, Linscheid MW, Saleh MI. Polyphenolic constituents of Callistemon lanceolatus leaves. Pharmazie 2002; 57: 494-496.
13. Lounasmaa M, Puri HS, Widen CJ. Phloroglucinol derivatives of Callistemon lanceolatus leaves. Phytochemistry 1977;16: 1851-52.
14. Marzouk SAM. An acylated flavonol glycoside and hydrolysable tannins from Callistemon lanceolatus flowers and leaves. Phytochemical analysis 2008; 19:541-549.
15. Ueda H, Kuroiwa E, Tachibana Y, Kawanishi K, Ayala F, Moriyasu M. Aldose reductase inhibitors from the leaves of Myrciaria dubia (H.B. and K.). Phytomedicine 2004; 11: 652-656.
16. Jung M, Park M, Lee HC, Kang Y, Kang ES, Kim SK. Antidiabetic agents from plants. Current Med Chem 2006;13: 1203-1218.
17. Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys 1981; 206: 296-304
18. Jollow DJ, Mitchell JR, Zampaglione N, Gillete JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974; 11: 151-169.
19. Yen G, Chen H. Antioxidant activity of various tea extract in relation to their antimutagenicity. J. Agricultural and Food Chemistry 1995; 43: 27-32.
20. Claiborne A. Catalase activity. In Greenwald, R.A. (ed.) CRC Handbook of Methods for Oxygen Radical Research. CRC Press, Boca Raton, 1985; FL 283-284.
21. Kawabata J, Mizuhata K, Sato E, Nishioka T, Aoyama Y, Kasai T. 6-Hydroxyflavonoid as α-Glucosidase Inhibitors from Marjoram (Origanum majorana) Leaves. Bioscience Biotechnology and Biochemistry 2003; 67: 445.
22. Matsuda, H., Morikawa T., Yoshikawa, M. Antidiabetogenic constituents from several natural medicines. Pure Applied Chemistry 2002; 74: 1301-1308.
23. Teotia S, Singh M. Hypoglycemic effect of Prunus mygdalus seeds in albino rabbits. Indian J. Experimental Biology 1997; 35:295-296.
24. Sakatani T, Shirayama T, Suzaki Y. The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease. Int. Heart J 2005; 46: 619-629.
25. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diab Metab 2000; 26: 163-176.